ReviewCurrent oncology (Toronto, Ont.)2023

Focus on Therapeutic Options for Surgically Resectable Pancreatic Adenocarcinoma Based on Novel Biomarkers.

Alessandro Olivari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.